TEOSYAL® PURESENSE REDENSITY II (2x1ml)

Product Overview: TEOSYAL® PURESENSE REDENSITY II (2x1ml)

TEOSYAL® PURESENSE REDENSITY II is a sterile, non-pyrogenic, viscoelastic gel uniquely formulated for the treatment of the delicate peri-orbital area, specifically under-eye circles and tear troughs. It features a specific blend of cross-linked and non-crosslinked hyaluronic acid (HA), combined with a patented Dermo-Restructuring Complex (8 amino acids, 3 antioxidants, 2 minerals, Vitamin B6) and 0.3% lidocaine hydrochloride for patient comfort. Manufactured by Teoxane Laboratories (Geneva, Switzerland), this product aims to subtly restore volume and improve skin quality in the challenging under-eye region.

It is indicated for the correction of fine lines, volume loss, and shadowing associated with tear troughs and under-eye circles.

Note: Due to the complexity and sensitivity of the peri-orbital area, this medical device must only be administered by qualified healthcare professionals with specific training and experience in tear trough correction techniques.

Mechanism of Action and Properties

TEOSYAL® PURESENSE REDENSITY II utilizes a precise combination of cross-linked HA (for subtle volume and longevity) and non-crosslinked HA (for hydration and spreadability). This blend is designed to have low hygroscopic behavior, minimizing the risk of excessive swelling (edema) post-injection in the thin under-eye skin. The HA provides gentle volume replacement to reduce hollowness and shadowing. Concurrently, the Dermo-Restructuring Complex delivers essential nutrients to support skin health, elasticity, and radiance in the treated area. The integrated 0.3% lidocaine hydrochloride provides local anesthesia for a more comfortable procedure.

The primary goal is natural-looking rejuvenation of the under-eye area, improving both volume deficits and skin quality.

Indications and Usage

TEOSYAL® PURESENSE REDENSITY II is specifically indicated for the aesthetic correction of the under-eye area, targeting concerns such as:

• Tear trough deformity (hollowness)
• Under-eye circles (particularly those caused by volume loss/shadowing)
• Palpebromalar groove
• Fine lines in the peri-orbital region
• Minimal/incipient malar bags (requires careful patient selection and technique)

Administration involves precise injection, often supra-periosteal or into the deep dermis/sub-orbicularis oculi plane, using appropriate techniques (needle or cannula) by highly skilled practitioners.

Expected Outcomes

Following appropriate treatment, anticipated outcomes include:

• Reduction in the appearance of tear trough hollowness and shadowing
• Smoother transition between the lower eyelid and cheek
• Improved skin hydration and texture in the under-eye area
• A refreshed, less tired appearance
• Natural-looking results respecting facial harmony

Potential Adverse Events

The peri-orbital area requires meticulous injection technique due to its anatomy and thin skin. Practitioners must discuss potential side effects thoroughly:

• Common Reactions (Often Transient, but potentially more noticeable): Swelling/edema (common in this area), bruising (higher risk due to vascularity), erythema (redness), pain/tenderness at injection sites, temporary lumpiness or unevenness.
• Less Common/Rare but Serious Reactions: Prolonged swelling or edema, Tyndall effect (bluish discoloration if injected too superficially), persistent lumps or nodules, inflammation, infection, hypersensitivity (to HA, complex, or lidocaine), vascular complications including visual disturbances (extremely rare but severe risk associated with peri-orbital injections requiring immediate expert management).

Expert knowledge of peri-orbital anatomy and complication management is paramount. Patients must report any severe, persistent, or concerning reactions immediately.

Storage Conditions

Store between 2°C and 25°C, protected from light and freezing. Ensure the packaging is intact before use.

Disclaimer: This overview provides general information. Healthcare professionals must consult the full instructions provided with TEOSYAL® PURESENSE REDENSITY II (2x1ml) before administration for comprehensive details regarding indications, contraindications, warnings, precautions, specific administration techniques for the tear trough, and potential adverse events.